Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New mechanism of action described for immunomodulating agent OM-89

Nov. 12, 1998

Rotavirus vaccine now on the market in U.S.

Nov. 6, 1998

Siga, U.S. Army collaborate on development of staphylococcal vaccine

Nov. 6, 1998

First Neoral equivalent cleared by FDA

Nov. 4, 1998

New immunosuppressants in the pipeline at Kyowa Hakko

Nov. 4, 1998

PTK inhibitors described by Knoll for immune and bone diseases

Nov. 3, 1998

SB and Corixa expand vaccine collaboration

Oct. 30, 1998

Nasally delivered flu vaccine safe and immunogenic in adults

Oct. 30, 1998

Phase III study evaluates efficacy of tacrolimus in bone marrow transplantation

Oct. 29, 1998

Aquila's malaria vaccine immunogenic and well tolerated in phase I trial

Oct. 28, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...